nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCB1—ovarian cancer	0.267	1	CbGaD
Pantoprazole—ABCG2—Topotecan—ovarian cancer	0.109	0.227	CbGbCtD
Pantoprazole—ABCG2—Paclitaxel—ovarian cancer	0.0539	0.113	CbGbCtD
Pantoprazole—ABCG2—Carboplatin—ovarian cancer	0.0507	0.106	CbGbCtD
Pantoprazole—ABCB1—Topotecan—ovarian cancer	0.0393	0.082	CbGbCtD
Pantoprazole—ABCG2—Docetaxel—ovarian cancer	0.039	0.0814	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—ovarian cancer	0.0291	0.0607	CbGbCtD
Pantoprazole—ABCB1—Vinorelbine—ovarian cancer	0.0277	0.0578	CbGbCtD
Pantoprazole—CYP3A4—Topotecan—ovarian cancer	0.0235	0.0491	CbGbCtD
Pantoprazole—CYP2C9—Paclitaxel—ovarian cancer	0.02	0.0418	CbGbCtD
Pantoprazole—ABCB1—Paclitaxel—ovarian cancer	0.0194	0.0406	CbGbCtD
Pantoprazole—CYP3A4—Vinorelbine—ovarian cancer	0.0166	0.0346	CbGbCtD
Pantoprazole—ABCB1—Docetaxel—ovarian cancer	0.0141	0.0293	CbGbCtD
Pantoprazole—CYP3A4—Paclitaxel—ovarian cancer	0.0116	0.0243	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—ovarian cancer	0.0105	0.0219	CbGbCtD
Pantoprazole—CYP3A4—Docetaxel—ovarian cancer	0.00842	0.0176	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—ovarian cancer	0.00628	0.0131	CbGbCtD
Pantoprazole—Omeprazole—CYP1B1—ovarian cancer	0.00175	0.406	CrCbGaD
Pantoprazole—Lansoprazole—CYP1B1—ovarian cancer	0.0016	0.371	CrCbGaD
Pantoprazole—Omeprazole—ABCB1—ovarian cancer	0.000501	0.116	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—ovarian cancer	0.000458	0.107	CrCbGaD
Pantoprazole—Fatigue—Paclitaxel—ovarian cancer	9.76e-05	0.000432	CcSEcCtD
Pantoprazole—Sweating—Epirubicin—ovarian cancer	9.72e-05	0.000431	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—ovarian cancer	9.72e-05	0.000431	CcSEcCtD
Pantoprazole—Pain—Paclitaxel—ovarian cancer	9.68e-05	0.000428	CcSEcCtD
Pantoprazole—Constipation—Paclitaxel—ovarian cancer	9.68e-05	0.000428	CcSEcCtD
Pantoprazole—Haematuria—Epirubicin—ovarian cancer	9.67e-05	0.000428	CcSEcCtD
Pantoprazole—Confusional state—Docetaxel—ovarian cancer	9.67e-05	0.000428	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—ovarian cancer	9.61e-05	0.000425	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—ovarian cancer	9.59e-05	0.000425	CcSEcCtD
Pantoprazole—Oedema—Docetaxel—ovarian cancer	9.59e-05	0.000425	CcSEcCtD
Pantoprazole—Anaphylactic shock—Docetaxel—ovarian cancer	9.59e-05	0.000425	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—ovarian cancer	9.58e-05	0.000424	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—ovarian cancer	9.57e-05	0.000424	CcSEcCtD
Pantoprazole—Infection—Docetaxel—ovarian cancer	9.53e-05	0.000422	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—ovarian cancer	9.52e-05	0.000422	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—ovarian cancer	9.52e-05	0.000421	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—ovarian cancer	9.5e-05	0.00042	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—ovarian cancer	9.47e-05	0.000419	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—ovarian cancer	9.44e-05	0.000418	CcSEcCtD
Pantoprazole—Shock—Docetaxel—ovarian cancer	9.44e-05	0.000418	CcSEcCtD
Pantoprazole—Nervous system disorder—Docetaxel—ovarian cancer	9.41e-05	0.000416	CcSEcCtD
Pantoprazole—Thrombocytopenia—Docetaxel—ovarian cancer	9.39e-05	0.000416	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—ovarian cancer	9.39e-05	0.000416	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—ovarian cancer	9.39e-05	0.000416	CcSEcCtD
Pantoprazole—Tachycardia—Docetaxel—ovarian cancer	9.36e-05	0.000414	CcSEcCtD
Pantoprazole—Feeling abnormal—Paclitaxel—ovarian cancer	9.33e-05	0.000413	CcSEcCtD
Pantoprazole—Skin disorder—Docetaxel—ovarian cancer	9.32e-05	0.000412	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	9.31e-05	0.000412	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	9.25e-05	0.00041	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	9.2e-05	0.000407	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—ovarian cancer	9.15e-05	0.000405	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—ovarian cancer	9.15e-05	0.000405	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—ovarian cancer	9.15e-05	0.000405	CcSEcCtD
Pantoprazole—Anorexia—Docetaxel—ovarian cancer	9.14e-05	0.000405	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—ovarian cancer	9.13e-05	0.000404	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—ovarian cancer	9.12e-05	0.000404	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—ovarian cancer	9.12e-05	0.000404	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—ovarian cancer	9.11e-05	0.000403	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—ovarian cancer	9.11e-05	0.000403	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—ovarian cancer	9.06e-05	0.000401	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—ovarian cancer	9.04e-05	0.0004	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—ovarian cancer	9e-05	0.000398	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—ovarian cancer	8.99e-05	0.000398	CcSEcCtD
Pantoprazole—Urticaria—Paclitaxel—ovarian cancer	8.99e-05	0.000398	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—ovarian cancer	8.97e-05	0.000397	CcSEcCtD
Pantoprazole—Hypotension—Docetaxel—ovarian cancer	8.96e-05	0.000397	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—ovarian cancer	8.95e-05	0.000396	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—ovarian cancer	8.95e-05	0.000396	CcSEcCtD
Pantoprazole—Abdominal pain—Paclitaxel—ovarian cancer	8.95e-05	0.000396	CcSEcCtD
Pantoprazole—Body temperature increased—Paclitaxel—ovarian cancer	8.95e-05	0.000396	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—ovarian cancer	8.93e-05	0.000395	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	8.88e-05	0.000393	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—ovarian cancer	8.85e-05	0.000392	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—ovarian cancer	8.81e-05	0.00039	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—ovarian cancer	8.78e-05	0.000389	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—ovarian cancer	8.76e-05	0.000388	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	8.74e-05	0.000387	CcSEcCtD
Pantoprazole—Insomnia—Docetaxel—ovarian cancer	8.68e-05	0.000384	CcSEcCtD
Pantoprazole—Paraesthesia—Docetaxel—ovarian cancer	8.61e-05	0.000381	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—ovarian cancer	8.61e-05	0.000381	CcSEcCtD
Pantoprazole—Dyspnoea—Docetaxel—ovarian cancer	8.55e-05	0.000379	CcSEcCtD
Pantoprazole—Somnolence—Docetaxel—ovarian cancer	8.53e-05	0.000378	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—ovarian cancer	8.51e-05	0.000377	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—ovarian cancer	8.49e-05	0.000376	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—ovarian cancer	8.47e-05	0.000375	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—ovarian cancer	8.45e-05	0.000374	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—ovarian cancer	8.45e-05	0.000374	CcSEcCtD
Pantoprazole—Dyspepsia—Docetaxel—ovarian cancer	8.44e-05	0.000374	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—ovarian cancer	8.43e-05	0.000373	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—ovarian cancer	8.43e-05	0.000373	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—ovarian cancer	8.38e-05	0.000371	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—ovarian cancer	8.36e-05	0.00037	CcSEcCtD
Pantoprazole—Decreased appetite—Docetaxel—ovarian cancer	8.34e-05	0.000369	CcSEcCtD
Pantoprazole—Hypersensitivity—Paclitaxel—ovarian cancer	8.34e-05	0.000369	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—ovarian cancer	8.32e-05	0.000368	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—ovarian cancer	8.3e-05	0.000367	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	8.28e-05	0.000367	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—ovarian cancer	8.28e-05	0.000367	CcSEcCtD
Pantoprazole—Fatigue—Docetaxel—ovarian cancer	8.27e-05	0.000366	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—ovarian cancer	8.26e-05	0.000366	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—ovarian cancer	8.23e-05	0.000364	CcSEcCtD
Pantoprazole—Pain—Docetaxel—ovarian cancer	8.2e-05	0.000363	CcSEcCtD
Pantoprazole—Constipation—Docetaxel—ovarian cancer	8.2e-05	0.000363	CcSEcCtD
Pantoprazole—Chills—Epirubicin—ovarian cancer	8.17e-05	0.000362	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—ovarian cancer	8.13e-05	0.00036	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—ovarian cancer	8.12e-05	0.000359	CcSEcCtD
Pantoprazole—Asthenia—Paclitaxel—ovarian cancer	8.12e-05	0.000359	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—ovarian cancer	8.05e-05	0.000356	CcSEcCtD
Pantoprazole—Pruritus—Paclitaxel—ovarian cancer	8.01e-05	0.000354	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—ovarian cancer	7.98e-05	0.000353	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—ovarian cancer	7.97e-05	0.000353	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—ovarian cancer	7.93e-05	0.000351	CcSEcCtD
Pantoprazole—Feeling abnormal—Docetaxel—ovarian cancer	7.9e-05	0.00035	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—ovarian cancer	7.87e-05	0.000349	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—ovarian cancer	7.86e-05	0.000348	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Docetaxel—ovarian cancer	7.84e-05	0.000347	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—ovarian cancer	7.82e-05	0.000346	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—ovarian cancer	7.81e-05	0.000346	CcSEcCtD
Pantoprazole—Tension—Epirubicin—ovarian cancer	7.78e-05	0.000344	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—ovarian cancer	7.76e-05	0.000344	CcSEcCtD
Pantoprazole—Diarrhoea—Paclitaxel—ovarian cancer	7.74e-05	0.000343	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—ovarian cancer	7.7e-05	0.000341	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—ovarian cancer	7.67e-05	0.000339	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—ovarian cancer	7.62e-05	0.000337	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—ovarian cancer	7.61e-05	0.000337	CcSEcCtD
Pantoprazole—Abdominal pain—Docetaxel—ovarian cancer	7.58e-05	0.000336	CcSEcCtD
Pantoprazole—Body temperature increased—Docetaxel—ovarian cancer	7.58e-05	0.000336	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—ovarian cancer	7.56e-05	0.000335	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—ovarian cancer	7.53e-05	0.000333	CcSEcCtD
Pantoprazole—Dizziness—Paclitaxel—ovarian cancer	7.48e-05	0.000331	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—ovarian cancer	7.47e-05	0.000331	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—ovarian cancer	7.45e-05	0.00033	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—ovarian cancer	7.38e-05	0.000327	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—ovarian cancer	7.35e-05	0.000326	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—ovarian cancer	7.33e-05	0.000325	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—ovarian cancer	7.33e-05	0.000324	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—ovarian cancer	7.28e-05	0.000323	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—ovarian cancer	7.23e-05	0.00032	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—ovarian cancer	7.2e-05	0.000319	CcSEcCtD
Pantoprazole—Vomiting—Paclitaxel—ovarian cancer	7.19e-05	0.000319	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—ovarian cancer	7.18e-05	0.000318	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—ovarian cancer	7.15e-05	0.000316	CcSEcCtD
Pantoprazole—Rash—Paclitaxel—ovarian cancer	7.13e-05	0.000316	CcSEcCtD
Pantoprazole—Dermatitis—Paclitaxel—ovarian cancer	7.13e-05	0.000316	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—ovarian cancer	7.12e-05	0.000315	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—ovarian cancer	7.12e-05	0.000315	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—ovarian cancer	7.11e-05	0.000315	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—ovarian cancer	7.1e-05	0.000314	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—ovarian cancer	7.09e-05	0.000314	CcSEcCtD
Pantoprazole—Headache—Paclitaxel—ovarian cancer	7.09e-05	0.000314	CcSEcCtD
Pantoprazole—Hypersensitivity—Docetaxel—ovarian cancer	7.07e-05	0.000313	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—ovarian cancer	7.05e-05	0.000312	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—ovarian cancer	7.01e-05	0.00031	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—ovarian cancer	6.97e-05	0.000308	CcSEcCtD
Pantoprazole—Cough—Epirubicin—ovarian cancer	6.92e-05	0.000306	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—ovarian cancer	6.91e-05	0.000306	CcSEcCtD
Pantoprazole—Asthenia—Docetaxel—ovarian cancer	6.88e-05	0.000305	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—ovarian cancer	6.87e-05	0.000304	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—ovarian cancer	6.84e-05	0.000303	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—ovarian cancer	6.81e-05	0.000301	CcSEcCtD
Pantoprazole—Pruritus—Docetaxel—ovarian cancer	6.79e-05	0.0003	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—ovarian cancer	6.78e-05	0.0003	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—ovarian cancer	6.75e-05	0.000299	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—ovarian cancer	6.75e-05	0.000299	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—ovarian cancer	6.75e-05	0.000299	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—ovarian cancer	6.74e-05	0.000298	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—ovarian cancer	6.73e-05	0.000298	CcSEcCtD
Pantoprazole—Nausea—Paclitaxel—ovarian cancer	6.72e-05	0.000298	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	6.7e-05	0.000297	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—ovarian cancer	6.67e-05	0.000295	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—ovarian cancer	6.61e-05	0.000293	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—ovarian cancer	6.6e-05	0.000292	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—ovarian cancer	6.59e-05	0.000292	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—ovarian cancer	6.58e-05	0.000291	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—ovarian cancer	6.57e-05	0.000291	CcSEcCtD
Pantoprazole—Diarrhoea—Docetaxel—ovarian cancer	6.56e-05	0.000291	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—ovarian cancer	6.52e-05	0.000289	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—ovarian cancer	6.48e-05	0.000287	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—ovarian cancer	6.47e-05	0.000286	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—ovarian cancer	6.47e-05	0.000286	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—ovarian cancer	6.45e-05	0.000285	CcSEcCtD
Pantoprazole—Infection—Epirubicin—ovarian cancer	6.43e-05	0.000285	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—ovarian cancer	6.4e-05	0.000283	CcSEcCtD
Pantoprazole—Shock—Epirubicin—ovarian cancer	6.36e-05	0.000282	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—ovarian cancer	6.35e-05	0.000281	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—ovarian cancer	6.34e-05	0.000281	CcSEcCtD
Pantoprazole—Dizziness—Docetaxel—ovarian cancer	6.34e-05	0.000281	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—ovarian cancer	6.33e-05	0.00028	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—ovarian cancer	6.33e-05	0.00028	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—ovarian cancer	6.31e-05	0.00028	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—ovarian cancer	6.28e-05	0.000278	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—ovarian cancer	6.25e-05	0.000277	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—ovarian cancer	6.24e-05	0.000276	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—ovarian cancer	6.24e-05	0.000276	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—ovarian cancer	6.24e-05	0.000276	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—ovarian cancer	6.22e-05	0.000276	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	6.2e-05	0.000275	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—ovarian cancer	6.17e-05	0.000273	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—ovarian cancer	6.17e-05	0.000273	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—ovarian cancer	6.11e-05	0.00027	CcSEcCtD
Pantoprazole—Vomiting—Docetaxel—ovarian cancer	6.1e-05	0.00027	CcSEcCtD
Pantoprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	6.07e-05	0.00257	CbGpPWpGaD
Pantoprazole—Rash—Docetaxel—ovarian cancer	6.05e-05	0.000268	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—ovarian cancer	6.05e-05	0.000268	CcSEcCtD
Pantoprazole—Dermatitis—Docetaxel—ovarian cancer	6.04e-05	0.000268	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—ovarian cancer	6.04e-05	0.000267	CcSEcCtD
Pantoprazole—Headache—Docetaxel—ovarian cancer	6.01e-05	0.000266	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—ovarian cancer	5.99e-05	0.000265	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—ovarian cancer	5.99e-05	0.000265	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—ovarian cancer	5.95e-05	0.000263	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.89e-05	0.000261	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—ovarian cancer	5.89e-05	0.000261	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—ovarian cancer	5.87e-05	0.00026	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—ovarian cancer	5.86e-05	0.000259	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—ovarian cancer	5.85e-05	0.000259	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—ovarian cancer	5.84e-05	0.000259	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—ovarian cancer	5.81e-05	0.000257	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—ovarian cancer	5.81e-05	0.000257	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—ovarian cancer	5.79e-05	0.000256	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—ovarian cancer	5.77e-05	0.000255	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—ovarian cancer	5.75e-05	0.000255	CcSEcCtD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.73e-05	0.00242	CbGpPWpGaD
Pantoprazole—Anorexia—Doxorubicin—ovarian cancer	5.71e-05	0.000253	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	5.7e-05	0.00241	CbGpPWpGaD
Pantoprazole—Nausea—Docetaxel—ovarian cancer	5.7e-05	0.000252	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—ovarian cancer	5.69e-05	0.000252	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.66e-05	0.0024	CbGpPWpGaD
Pantoprazole—Decreased appetite—Epirubicin—ovarian cancer	5.62e-05	0.000249	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—ovarian cancer	5.59e-05	0.000248	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	5.59e-05	0.000247	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—ovarian cancer	5.58e-05	0.000247	CcSEcCtD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	5.57e-05	0.00236	CbGpPWpGaD
Pantoprazole—Pain—Epirubicin—ovarian cancer	5.53e-05	0.000245	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—ovarian cancer	5.53e-05	0.000245	CcSEcCtD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.53e-05	0.00234	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	5.5e-05	0.00233	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.49e-05	0.00232	CbGpPWpGaD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	5.45e-05	0.000241	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—ovarian cancer	5.41e-05	0.00024	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—ovarian cancer	5.38e-05	0.000238	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—ovarian cancer	5.34e-05	0.000236	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—ovarian cancer	5.33e-05	0.000236	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—ovarian cancer	5.32e-05	0.000236	CcSEcCtD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—AQP3—ovarian cancer	5.3e-05	0.00224	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	5.29e-05	0.00224	CbGpPWpGaD
Pantoprazole—Gastrointestinal pain—Epirubicin—ovarian cancer	5.29e-05	0.000234	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—ovarian cancer	5.27e-05	0.000233	CcSEcCtD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	5.26e-05	0.00223	CbGpPWpGaD
Pantoprazole—Decreased appetite—Doxorubicin—ovarian cancer	5.2e-05	0.00023	CcSEcCtD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	5.19e-05	0.0022	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	5.19e-05	0.0022	CbGpPWpGaD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.17e-05	0.000229	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—ovarian cancer	5.16e-05	0.000228	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—ovarian cancer	5.14e-05	0.000228	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—ovarian cancer	5.12e-05	0.000227	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—ovarian cancer	5.12e-05	0.000227	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—ovarian cancer	5.11e-05	0.000226	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—ovarian cancer	5.11e-05	0.000226	CcSEcCtD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	5.08e-05	0.00215	CbGpPWpGaD
Pantoprazole—Feeling abnormal—Doxorubicin—ovarian cancer	4.93e-05	0.000218	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.89e-05	0.000217	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—ovarian cancer	4.77e-05	0.000211	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—ovarian cancer	4.76e-05	0.000211	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—ovarian cancer	4.73e-05	0.00021	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—ovarian cancer	4.73e-05	0.00021	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—ovarian cancer	4.64e-05	0.000206	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—ovarian cancer	4.58e-05	0.000203	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—NME2—ovarian cancer	4.48e-05	0.0019	CbGpPWpGaD
Pantoprazole—Diarrhoea—Epirubicin—ovarian cancer	4.43e-05	0.000196	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—ovarian cancer	4.41e-05	0.000195	CcSEcCtD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.34e-05	0.00184	CbGpPWpGaD
Pantoprazole—Asthenia—Doxorubicin—ovarian cancer	4.29e-05	0.00019	CcSEcCtD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	4.29e-05	0.00181	CbGpPWpGaD
Pantoprazole—Dizziness—Epirubicin—ovarian cancer	4.28e-05	0.000189	CcSEcCtD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	4.26e-05	0.0018	CbGpPWpGaD
Pantoprazole—Pruritus—Doxorubicin—ovarian cancer	4.24e-05	0.000188	CcSEcCtD
Pantoprazole—ABCG2—Metabolism—NME2—ovarian cancer	4.15e-05	0.00175	CbGpPWpGaD
Pantoprazole—Vomiting—Epirubicin—ovarian cancer	4.11e-05	0.000182	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—ovarian cancer	4.1e-05	0.000181	CcSEcCtD
Pantoprazole—Rash—Epirubicin—ovarian cancer	4.08e-05	0.000181	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—ovarian cancer	4.08e-05	0.00018	CcSEcCtD
Pantoprazole—Headache—Epirubicin—ovarian cancer	4.05e-05	0.000179	CcSEcCtD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	4.02e-05	0.0017	CbGpPWpGaD
Pantoprazole—Dizziness—Doxorubicin—ovarian cancer	3.96e-05	0.000175	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—ovarian cancer	3.84e-05	0.00017	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—ovarian cancer	3.81e-05	0.000169	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.8e-05	0.00161	CbGpPWpGaD
Pantoprazole—Rash—Doxorubicin—ovarian cancer	3.77e-05	0.000167	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—ovarian cancer	3.77e-05	0.000167	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	3.77e-05	0.00159	CbGpPWpGaD
Pantoprazole—Headache—Doxorubicin—ovarian cancer	3.75e-05	0.000166	CcSEcCtD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	3.72e-05	0.00157	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	3.71e-05	0.00157	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	3.6e-05	0.00152	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	3.6e-05	0.00152	CbGpPWpGaD
Pantoprazole—Nausea—Doxorubicin—ovarian cancer	3.56e-05	0.000157	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	3.52e-05	0.00149	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	3.43e-05	0.00145	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	3.39e-05	0.00144	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	3.39e-05	0.00143	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.31e-05	0.0014	CbGpPWpGaD
Pantoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.28e-05	0.00139	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.18e-05	0.00135	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.1e-05	0.00131	CbGpPWpGaD
Pantoprazole—ATP4A—epithelium—ovarian cancer	3.06e-05	0.135	CbGeAlD
Pantoprazole—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.99e-05	0.00127	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.99e-05	0.00127	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.96e-05	0.00125	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.94e-05	0.00124	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.9e-05	0.00123	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.9e-05	0.00123	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.89e-05	0.00123	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYTB—ovarian cancer	2.89e-05	0.00122	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.87e-05	0.00122	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.87e-05	0.00121	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.87e-05	0.00121	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.86e-05	0.00121	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.82e-05	0.00119	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.81e-05	0.00119	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.8e-05	0.00118	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.78e-05	0.00118	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.75e-05	0.00117	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.75e-05	0.00116	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.73e-05	0.00116	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.69e-05	0.00114	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.69e-05	0.00114	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.69e-05	0.00114	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.68e-05	0.00114	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYTB—ovarian cancer	2.67e-05	0.00113	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.65e-05	0.00112	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.59e-05	0.0011	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.54e-05	0.00108	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	2.52e-05	0.00107	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—BRIP1—ovarian cancer	2.52e-05	0.00107	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.43e-05	0.00103	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—BRIP1—ovarian cancer	2.34e-05	0.000988	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPP1CC—ovarian cancer	2.34e-05	0.000988	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NME2—ovarian cancer	2.3e-05	0.000972	CbGpPWpGaD
Pantoprazole—ATP4A—female reproductive system—ovarian cancer	2.27e-05	0.0999	CbGeAlD
Pantoprazole—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.27e-05	0.000959	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.26e-05	0.000958	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NME2—ovarian cancer	2.24e-05	0.000949	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.23e-05	0.000946	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.21e-05	0.000935	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.17e-05	0.00092	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.16e-05	0.000915	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.12e-05	0.000899	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NME2—ovarian cancer	2.09e-05	0.000886	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.04e-05	0.000865	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.01e-05	0.00085	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.95e-05	0.000825	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.84e-05	0.000778	CbGpPWpGaD
Pantoprazole—ATP4A—testis—ovarian cancer	1.83e-05	0.0807	CbGeAlD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.79e-05	0.000758	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NME2—ovarian cancer	1.79e-05	0.000757	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.78e-05	0.000752	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—YAP1—ovarian cancer	1.69e-05	0.000716	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.67e-05	0.000709	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.59e-05	0.000672	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—YAP1—ovarian cancer	1.57e-05	0.000663	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.56e-05	0.00066	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.52e-05	0.000643	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYTB—ovarian cancer	1.48e-05	0.000626	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.47e-05	0.000623	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.45e-05	0.000614	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.45e-05	0.000613	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.45e-05	0.000612	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYTB—ovarian cancer	1.44e-05	0.000611	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.44e-05	0.000611	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.41e-05	0.000599	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.4e-05	0.000593	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NME2—ovarian cancer	1.38e-05	0.000585	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—FASN—ovarian cancer	1.38e-05	0.000584	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.38e-05	0.000583	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.36e-05	0.000577	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.36e-05	0.000574	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYTB—ovarian cancer	1.35e-05	0.000571	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.33e-05	0.000562	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.32e-05	0.000558	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.31e-05	0.000555	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.29e-05	0.000548	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.29e-05	0.000548	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.28e-05	0.000543	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—FASN—ovarian cancer	1.28e-05	0.00054	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.26e-05	0.000534	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BRIP1—ovarian cancer	1.26e-05	0.000534	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.26e-05	0.000532	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.26e-05	0.000532	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.24e-05	0.000524	CbGpPWpGaD
Pantoprazole—SLCO1B1—female reproductive system—ovarian cancer	1.22e-05	0.0536	CbGeAlD
Pantoprazole—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.21e-05	0.000513	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.2e-05	0.000508	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.18e-05	0.000499	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.18e-05	0.000499	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.16e-05	0.000492	CbGpPWpGaD
Pantoprazole—ABCG2—myometrium—ovarian cancer	1.16e-05	0.0508	CbGeAlD
Pantoprazole—CYP1A2—Metabolism—CYTB—ovarian cancer	1.15e-05	0.000488	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.14e-05	0.000481	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.13e-05	0.000477	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.11e-05	0.000471	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.11e-05	0.000469	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.1e-05	0.000467	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.08e-05	0.000457	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.08e-05	0.000457	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.03e-05	0.000438	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.03e-05	0.000437	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.02e-05	0.000432	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.02e-05	0.00043	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.01e-05	0.000427	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.01e-05	0.000427	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ABCB1—ovarian cancer	9.58e-06	0.000405	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.43e-06	0.000399	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TYMS—ovarian cancer	9.41e-06	0.000398	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.38e-06	0.000397	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.07e-06	0.000384	CbGpPWpGaD
Pantoprazole—ABCG2—uterine cervix—ovarian cancer	8.99e-06	0.0395	CbGeAlD
Pantoprazole—CYP3A4—Metabolism—CYTB—ovarian cancer	8.9e-06	0.000377	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—YAP1—ovarian cancer	8.68e-06	0.000367	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.6e-06	0.000364	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.59e-06	0.000363	CbGpPWpGaD
Pantoprazole—ABCG2—decidua—ovarian cancer	8.56e-06	0.0377	CbGeAlD
Pantoprazole—ABCB1—Metabolism—YAP1—ovarian cancer	8.47e-06	0.000358	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CAV1—ovarian cancer	8.19e-06	0.000346	CbGpPWpGaD
Pantoprazole—ABCG2—endometrium—ovarian cancer	8.13e-06	0.0358	CbGeAlD
Pantoprazole—CYP2C9—Metabolism—YAP1—ovarian cancer	7.91e-06	0.000335	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.83e-06	0.000331	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.82e-06	0.000331	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.78e-06	0.000329	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.78e-06	0.000329	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.66e-06	0.000324	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CAV1—ovarian cancer	7.58e-06	0.000321	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.55e-06	0.00032	CbGpPWpGaD
Pantoprazole—ABCG2—uterus—ovarian cancer	7.49e-06	0.033	CbGeAlD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	7.46e-06	0.000316	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.35e-06	0.000311	CbGpPWpGaD
Pantoprazole—CYP2C19—vagina—ovarian cancer	7.18e-06	0.0316	CbGeAlD
Pantoprazole—CYP2C19—Metabolism—FASN—ovarian cancer	7.07e-06	0.000299	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.96e-06	0.000294	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.9e-06	0.000292	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—FASN—ovarian cancer	6.9e-06	0.000292	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.88e-06	0.000291	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.79e-06	0.000287	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—YAP1—ovarian cancer	6.76e-06	0.000286	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.72e-06	0.000284	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.69e-06	0.000283	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.58e-06	0.000278	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.56e-06	0.000278	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	6.55e-06	0.000277	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—FASN—ovarian cancer	6.45e-06	0.000273	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.44e-06	0.000273	CbGpPWpGaD
Pantoprazole—ABCG2—bone marrow—ovarian cancer	6.36e-06	0.028	CbGeAlD
Pantoprazole—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.34e-06	0.000269	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.29e-06	0.000266	CbGpPWpGaD
Pantoprazole—CYP2C9—female reproductive system—ovarian cancer	6.15e-06	0.0271	CbGeAlD
Pantoprazole—ABCG2—female gonad—ovarian cancer	6.13e-06	0.027	CbGeAlD
Pantoprazole—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.13e-06	0.000259	CbGpPWpGaD
Pantoprazole—ABCG2—vagina—ovarian cancer	6.09e-06	0.0268	CbGeAlD
Pantoprazole—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.07e-06	0.000257	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6e-06	0.000254	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.88e-06	0.000249	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.87e-06	0.000249	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.71e-06	0.000242	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	5.71e-06	0.000242	CbGpPWpGaD
Pantoprazole—ABCB1—myometrium—ovarian cancer	5.7e-06	0.0251	CbGeAlD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.69e-06	0.000241	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.58e-06	0.000236	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—FASN—ovarian cancer	5.51e-06	0.000233	CbGpPWpGaD
Pantoprazole—ABCB1—embryo—ovarian cancer	5.48e-06	0.0241	CbGeAlD
Pantoprazole—ABCG2—testis—ovarian cancer	5.44e-06	0.0239	CbGeAlD
Pantoprazole—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.42e-06	0.000229	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.3e-06	0.000225	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.29e-06	0.000224	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.24e-06	0.000222	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—YAP1—ovarian cancer	5.22e-06	0.000221	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMS—ovarian cancer	5.21e-06	0.000221	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.21e-06	0.00022	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.18e-06	0.000219	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.13e-06	0.000217	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMS—ovarian cancer	5.09e-06	0.000215	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1B1—ovarian cancer	5.02e-06	0.000212	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—ovarian cancer	4.94e-06	0.000209	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.84e-06	0.000205	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMS—ovarian cancer	4.75e-06	0.000201	CbGpPWpGaD
Pantoprazole—CYP3A4—female reproductive system—ovarian cancer	4.69e-06	0.0206	CbGeAlD
Pantoprazole—ABCG2—Metabolism—PTEN—ovarian cancer	4.57e-06	0.000193	CbGpPWpGaD
Pantoprazole—ABCB1—epithelium—ovarian cancer	4.47e-06	0.0197	CbGeAlD
Pantoprazole—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.45e-06	0.000188	CbGpPWpGaD
Pantoprazole—ABCB1—uterine cervix—ovarian cancer	4.43e-06	0.0195	CbGeAlD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.43e-06	0.000188	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—FASN—ovarian cancer	4.25e-06	0.00018	CbGpPWpGaD
Pantoprazole—ABCB1—decidua—ovarian cancer	4.22e-06	0.0186	CbGeAlD
Pantoprazole—CYP2C19—Metabolism—CAV1—ovarian cancer	4.2e-06	0.000178	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.18e-06	0.000177	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.13e-06	0.000175	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAV1—ovarian cancer	4.1e-06	0.000173	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMS—ovarian cancer	4.06e-06	0.000172	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.04e-06	0.000171	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.01e-06	0.00017	CbGpPWpGaD
Pantoprazole—ABCB1—endometrium—ovarian cancer	4.01e-06	0.0176	CbGeAlD
Pantoprazole—ABCG2—lymph node—ovarian cancer	3.94e-06	0.0173	CbGeAlD
Pantoprazole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.87e-06	0.000164	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAV1—ovarian cancer	3.83e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.82e-06	0.000162	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.73e-06	0.000158	CbGpPWpGaD
Pantoprazole—ABCB1—gonad—ovarian cancer	3.72e-06	0.0164	CbGeAlD
Pantoprazole—ABCB1—uterus—ovarian cancer	3.69e-06	0.0163	CbGeAlD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.66e-06	0.000155	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.49e-06	0.000148	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	3.48e-06	0.000147	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.44e-06	0.000145	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.36e-06	0.000142	CbGpPWpGaD
Pantoprazole—ABCB1—female reproductive system—ovarian cancer	3.32e-06	0.0146	CbGeAlD
Pantoprazole—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.28e-06	0.000139	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAV1—ovarian cancer	3.27e-06	0.000138	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.22e-06	0.000136	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.19e-06	0.000135	CbGpPWpGaD
Pantoprazole—ABCB1—bone marrow—ovarian cancer	3.14e-06	0.0138	CbGeAlD
Pantoprazole—CYP3A4—Metabolism—TYMS—ovarian cancer	3.13e-06	0.000133	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.13e-06	0.000132	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.07e-06	0.00013	CbGpPWpGaD
Pantoprazole—ABCB1—female gonad—ovarian cancer	3.02e-06	0.0133	CbGeAlD
Pantoprazole—ABCB1—vagina—ovarian cancer	3e-06	0.0132	CbGeAlD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.98e-06	0.000126	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.93e-06	0.000124	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.86e-06	0.000121	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.85e-06	0.00012	CbGpPWpGaD
Pantoprazole—ABCB1—testis—ovarian cancer	2.68e-06	0.0118	CbGeAlD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.67e-06	0.000113	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—ovarian cancer	2.63e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.62e-06	0.000111	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—ovarian cancer	2.53e-06	0.000107	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAV1—ovarian cancer	2.52e-06	0.000107	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—ovarian cancer	2.47e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—ovarian cancer	2.31e-06	9.77e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.3e-06	9.73e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.28e-06	9.66e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.02e-06	8.56e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—ovarian cancer	1.97e-06	8.35e-05	CbGpPWpGaD
Pantoprazole—ABCB1—lymph node—ovarian cancer	1.94e-06	0.00855	CbGeAlD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.79e-06	7.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.76e-06	7.46e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.74e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.63e-06	6.89e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—ovarian cancer	1.52e-06	6.44e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—ovarian cancer	1.46e-06	6.18e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—ovarian cancer	1.42e-06	6.03e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.39e-06	5.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—ovarian cancer	1.33e-06	5.63e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—ovarian cancer	1.14e-06	4.81e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.07e-06	4.55e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—ovarian cancer	8.77e-07	3.71e-05	CbGpPWpGaD
